Nova Laboratories Limited   Report issue

For profit Phase 1 Phase 2
Founded: Wigston United Kingdom (1994)

Organization Overview

First Clinical Trial
2012
NCT01680003
First Marketed Drug
2014
mercaptopurine (purinethol)
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Nova Laboratories Limited | Nova Laboratories Sdn Bhd | NOVA LABS LTD